Trial site
OncoCare Cancer Centre | Gleneagles Medical Centre
Singapore, 258499, SingaporeNot linked to an institution yet
The trials here
What the 4 trials at this site are about, from their registry records.
- Phase
- Phase 22 trials
- Phase 11 trial
- Phase 31 trial
- Status
- Active, not recruiting3 trials
- Not yet recruiting1 trial
- Lead sponsor
- Bayer2 trials
- Daiichi Sankyo1 trial
- Vividion Therapeutics, Inc.1 trial
Running trials
Recruiting
A Study to Evaluate the Efficacy of VVD-133214 in Combination With Pembrolizumab Compared With Pembrolizumab Alone in Participants With Advanced Cancer of the Colon or Rectum
NCT07811193· Phase 2· Vividion Therapeutics, Inc.· Source
Recruiting
A Study to Learn More About How Well Sevabertinib Works and How Safe it is Compared With Standard Treatment, in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
NCT06452277· Phase 3· Bayer· Source
Active, not recruiting
A First-in-human Study to Learn How Safe the Study Drug BAY3375968, an Anti-CCR8 Antibody, is, When Given Alone or in Combination With Pembrolizumab, How it Affects the Body, How it Moves Into, Through, and Out of the Body, and to Find the Best Dose in Participants With Advanced Solid Tumors
NCT05537740· Phase 1· Bayer· Source
Active, not recruiting
HERTHENA-Lung01: Patritumab Deruxtecan in Subjects With Metastatic or Locally Advanced EGFR-mutated Non-Small Cell Lung Cancer
NCT04619004· Phase 2· Daiichi Sankyo· Source
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
Report an error